Logo image of EXE

EXPAND ENERGY CORP (EXE) Stock Fundamental Analysis

NASDAQ:EXE - Nasdaq - US1651677353 - Common Stock - Currency: USD

111.19  -5.75 (-4.92%)

After market: 111.18 -0.01 (-0.01%)

Fundamental Rating

3

EXE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of EXE have multiple concerns. EXE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EXE was profitable.
In the past year EXE had a positive cash flow from operations.
In multiple years EXE reported negative net income over the last 5 years.
Each year in the past 5 years EXE had a positive operating cash flow.
EXE Yearly Net Income VS EBIT VS OCF VS FCFEXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -3.54%, EXE is doing worse than 76.30% of the companies in the same industry.
With a Return On Equity value of -5.75%, EXE is not doing good in the industry: 71.09% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.54%
ROE -5.75%
ROIC N/A
ROA(3y)15.25%
ROA(5y)-8.99%
ROE(3y)23.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXE Yearly ROA, ROE, ROICEXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

The Gross Margin of EXE (63.43%) is better than 72.04% of its industry peers.
EXE's Gross Margin has declined in the last couple of years.
EXE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.59%
EXE Yearly Profit, Operating, Gross MarginsEXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

2

2. Health

2.1 Basic Checks

EXE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXE has been increased compared to 1 year ago.
The number of shares outstanding for EXE has been increased compared to 5 years ago.
EXE has a worse debt/assets ratio than last year.
EXE Yearly Shares OutstandingEXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXE Yearly Total Debt VS Total AssetsEXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

EXE has an Altman-Z score of 1.72. This is a bad value and indicates that EXE is not financially healthy and even has some risk of bankruptcy.
EXE has a better Altman-Z score (1.72) than 60.66% of its industry peers.
EXE has a debt to FCF ratio of 12.79. This is a negative value and a sign of low solvency as EXE would need 12.79 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.79, EXE is in line with its industry, outperforming 48.34% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that EXE is not too dependend on debt financing.
EXE's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. EXE outperforms 62.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 12.79
Altman-Z 1.72
ROIC/WACCN/A
WACC8.17%
EXE Yearly LT Debt VS Equity VS FCFEXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

2.3 Liquidity

EXE has a Current Ratio of 0.59. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.59, EXE is doing worse than 81.04% of the companies in the same industry.
EXE has a Quick Ratio of 0.59. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a Quick ratio of 0.59. This is in the lower half of the industry: EXE underperforms 75.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
EXE Yearly Current Assets VS Current LiabilitesEXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The earnings per share for EXE have decreased strongly by -23.89% in the last year.
The earnings per share for EXE have been decreasing by -60.58% on average. This is quite bad
The Revenue has decreased by -8.50% in the past year.
Measured over the past years, EXE shows a very negative growth in Revenue. The Revenue has been decreasing by -13.27% on average per year.
EPS 1Y (TTM)-23.89%
EPS 3Y-60.58%
EPS 5YN/A
EPS Q2Q%260.71%
Revenue 1Y (TTM)-8.5%
Revenue growth 3Y-10.19%
Revenue growth 5Y-13.27%
Sales Q2Q%104.66%

3.2 Future

The Earnings Per Share is expected to grow by 64.72% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 30.99% on average over the next years. This is a very strong growth
EPS Next Y535.59%
EPS Next 2Y197.31%
EPS Next 3Y92.02%
EPS Next 5Y64.72%
Revenue Next Year162.54%
Revenue Next 2Y73.57%
Revenue Next 3Y45.64%
Revenue Next 5Y30.99%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXE Yearly Revenue VS EstimatesEXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
EXE Yearly EPS VS EstimatesEXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.58 indicates a quite expensive valuation of EXE.
Compared to the rest of the industry, the Price/Earnings ratio of EXE indicates a slightly more expensive valuation: EXE is more expensive than 65.40% of the companies listed in the same industry.
EXE's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.21.
EXE is valuated reasonably with a Price/Forward Earnings ratio of 9.83.
EXE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXE is cheaper than 64.93% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.70, EXE is valued rather cheaply.
Industry RankSector Rank
PE 40.58
Fwd PE 9.83
EXE Price Earnings VS Forward Price EarningsEXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

EXE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EXE is more expensive than 71.09% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 64.54
EV/EBITDA 35.19
EXE Per share dataEXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

EXE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXE's earnings are expected to grow with 92.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y197.31%
EPS Next 3Y92.02%

2

5. Dividend

5.1 Amount

EXE has a Yearly Dividend Yield of 1.94%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 6.66, EXE is paying slightly less dividend.
EXE's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.94%

5.2 History

The dividend of EXE decreases each year by -29.99%.
EXE has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-29.99%
Div Incr Years0
Div Non Decr Years0
EXE Yearly Dividends per shareEXE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

The earnings of EXE are negative and hence is the payout ratio. EXE will probably not be able to sustain this dividend level.
DP-45.8%
EPS Next 2Y197.31%
EPS Next 3Y92.02%
EXE Yearly Income VS Free CF VS DividendEXE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

EXPAND ENERGY CORP

NASDAQ:EXE (7/1/2025, 8:19:55 PM)

After market: 111.18 -0.01 (-0.01%)

111.19

-5.75 (-4.92%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners91.84%
Inst Owner ChangeN/A
Ins Owners2.78%
Ins Owner Change26.49%
Market Cap26.46B
Analysts83.13
Price Target131.97 (18.69%)
Short Float %4.87%
Short Ratio3.69
Dividend
Industry RankSector Rank
Dividend Yield 1.94%
Yearly Dividend2.14
Dividend Growth(5Y)-29.99%
DP-45.8%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-15 2025-05-15 (0.575)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.19%
Min EPS beat(2)6.21%
Max EPS beat(2)14.16%
EPS beat(4)4
Avg EPS beat(4)210.24%
Min EPS beat(4)6.21%
Max EPS beat(4)464.01%
EPS beat(8)7
Avg EPS beat(8)130.43%
EPS beat(12)11
Avg EPS beat(12)94.13%
EPS beat(16)14
Avg EPS beat(16)76.81%
Revenue beat(2)1
Avg Revenue beat(2)-6.38%
Min Revenue beat(2)-14.75%
Max Revenue beat(2)1.99%
Revenue beat(4)1
Avg Revenue beat(4)-14.4%
Min Revenue beat(4)-36.48%
Max Revenue beat(4)1.99%
Revenue beat(8)4
Avg Revenue beat(8)0.71%
Revenue beat(12)8
Avg Revenue beat(12)27.21%
Revenue beat(16)9
Avg Revenue beat(16)20.68%
PT rev (1m)4.83%
PT rev (3m)6.44%
EPS NQ rev (1m)-0.85%
EPS NQ rev (3m)-0.87%
EPS NY rev (1m)0.33%
EPS NY rev (3m)7.85%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)8%
Revenue NY rev (1m)3.02%
Revenue NY rev (3m)16.31%
Valuation
Industry RankSector Rank
PE 40.58
Fwd PE 9.83
P/S 4.97
P/FCF 64.54
P/OCF 12.55
P/B 1.54
P/tB 1.54
EV/EBITDA 35.19
EPS(TTM)2.74
EY2.46%
EPS(NY)11.31
Fwd EY10.18%
FCF(TTM)1.72
FCFY1.55%
OCF(TTM)8.86
OCFY7.97%
SpS22.35
BVpS72.24
TBVpS72.24
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.54%
ROE -5.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.43%
FCFM 7.71%
ROA(3y)15.25%
ROA(5y)-8.99%
ROE(3y)23.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.59%
F-Score2
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 12.79
Debt/EBITDA 5.64
Cap/Depr 83.24%
Cap/Sales 31.94%
Interest Coverage N/A
Cash Conversion 226.77%
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z 1.72
F-Score2
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)104.61%
Cap/Depr(5y)98.42%
Cap/Sales(3y)25.52%
Cap/Sales(5y)22.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.89%
EPS 3Y-60.58%
EPS 5YN/A
EPS Q2Q%260.71%
EPS Next Y535.59%
EPS Next 2Y197.31%
EPS Next 3Y92.02%
EPS Next 5Y64.72%
Revenue 1Y (TTM)-8.5%
Revenue growth 3Y-10.19%
Revenue growth 5Y-13.27%
Sales Q2Q%104.66%
Revenue Next Year162.54%
Revenue Next 2Y73.57%
Revenue Next 3Y45.64%
Revenue Next 5Y30.99%
EBIT growth 1Y-250.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5364.18%
EBIT Next 3Y291.66%
EBIT Next 5Y177.56%
FCF growth 1Y-81.24%
FCF growth 3Y-80.34%
FCF growth 5YN/A
OCF growth 1Y-49.32%
OCF growth 3Y-4.34%
OCF growth 5Y-0.73%